Literature DB >> 16776653

Structure-guided design of a novel class of benzyl-sulfonate inhibitors for influenza virus neuraminidase.

Dimitris Platis1, Brian J Smith, Trevor Huyton, Nikolaos E Labrou.   

Abstract

Influenza NA (neuraminidase) is an antiviral target of high pharmaceutical interest because of its essential role in cleaving sialic acid residues from cell surface glycoproteins and facilitating release of virions from infected cells. The present paper describes the use of structural information in the progressive design from a lead binding ion (a sulfate) to a potent submicromolor inhibitor (K(i) 0.13 microM). Structural information derived from the X-ray structure of an NA complexed with several sulfate ions, in combination with results derived from affinity labelling and molecular modelling studies, was used to guide design of potent sulfonic acid-based inhibitors. These inhibitors are structural fragments of the polysulfonate triazine dye Cibacron Blue 3GA and represent novel lead scaffolds for designing non-carbohydrate inhibitors for influenza neuraminidases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16776653      PMCID: PMC1609911          DOI: 10.1042/BJ20060447

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  38 in total

Review 1.  Design and selection of ligands for affinity chromatography.

Authors:  N E Labrou
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2003-06-25       Impact factor: 3.205

2.  Structure of a calcium-deficient form of influenza virus neuraminidase: implications for substrate binding.

Authors:  Brian J Smith; Trevor Huyton; Robbie P Joosten; Jennifer L McKimm-Breschkin; Jian Guo Zhang; Cindy S Luo; Mei Zhen Lou; Nikolaos E Labrou; Thomas P J Garrett
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2006-08-19

3.  What can we learn from reconstructing the extinct 1918 pandemic influenza virus?

Authors:  Peter Palese; Terrence M Tumpey; Adolfo Garcia-Sastre
Journal:  Immunity       Date:  2006-02       Impact factor: 31.745

4.  Characterization of temperature sensitive influenza virus mutants defective in neuraminidase.

Authors:  P Palese; K Tobita; M Ueda; R W Compans
Journal:  Virology       Date:  1974-10       Impact factor: 3.616

5.  Spectral changes induced in Cibacron Blue F3GA by salts, organic solvents, and polypeptides: implications for blue dye interaction with proteins.

Authors:  S Subramanian
Journal:  Arch Biochem Biophys       Date:  1982-06       Impact factor: 4.013

6.  Design and applications of biomimetic anthraquinone dyes. III. Anthraquinone-immobilised C.I. reactive blue 2 analogues and their interaction with horse liver alcohol dehydrogenase and other adenine nucleotide-binding proteins.

Authors:  S J Burton; C V Stead; C R Lowe
Journal:  J Chromatogr       Date:  1990-05-25

7.  Synthesis and evaluation of affinity adsorbents for glycoproteins: an artificial lectin.

Authors:  U D Palanisamy; D J Winzor; C R Lowe
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2000-09-15

8.  Design, synthesis, and structural analysis of inhibitors of influenza neuraminidase containing a 2,3-disubstituted tetrahydrofuran-5-carboxylic acid core.

Authors:  Gary T Wang; Sheldon Wang; Robert Gentles; Thomas Sowin; Clarence J Maring; Dale J Kempf; Warren M Kati; Vincent Stoll; Kent D Stewart; Graeme Laver
Journal:  Bioorg Med Chem Lett       Date:  2005-01-03       Impact factor: 2.823

9.  Lock-and-key motif as a concept for designing affinity adsorbents for protein purification.

Authors:  Dimitris Platis; Christoph A Sotriffer; Yannis Clonis; Nikolaos E Labrou
Journal:  J Chromatogr A       Date:  2006-07-24       Impact factor: 4.759

10.  Rational combinatorial chemistry-based selection, synthesis and evaluation of an affinity adsorbent for recombinant human clotting factor VII.

Authors:  Paul R Morrill; Geeta Gupta; Kenny Sproule; Don Winzor; Jesper Christensen; Inger Mollerup; Christopher R Lowe
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2002-07-05       Impact factor: 3.205

View more
  3 in total

1.  Implications of protein conformations to modifying novel inhibitor Oseltamivir for 2009 H1N1 influenza A virus by simulation and docking studies.

Authors:  Sudha Singh; Anvita Gupta Malhotra; Mohit Jha; Khushhali Menaria Pandey
Journal:  Virusdisease       Date:  2018-09-01

2.  The Interaction of Human Glutathione Transferase GSTA1-1 with Reactive Dyes.

Authors:  Mohammed Hamed Alqarni; Ahmed Ibrahim Foudah; Magdy Mohamed Muharram; Nikolaos E Labrou
Journal:  Molecules       Date:  2021-04-20       Impact factor: 4.411

3.  CrystalDock: a novel approach to fragment-based drug design.

Authors:  Jacob D Durrant; Aaron J Friedman; J Andrew McCammon
Journal:  J Chem Inf Model       Date:  2011-10-05       Impact factor: 4.956

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.